Foghorn Therapeutics (FHTX) Payables (2020 - 2025)
Historic Payables for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $9.8 million.
- Foghorn Therapeutics' Payables fell 1245.21% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 1245.21%. This contributed to the annual value of $8.5 million for FY2024, which is 633.51% down from last year.
- Per Foghorn Therapeutics' latest filing, its Payables stood at $9.8 million for Q3 2025, which was down 1245.21% from $8.6 million recorded in Q2 2025.
- Foghorn Therapeutics' 5-year Payables high stood at $11.2 million for Q3 2024, and its period low was $2.9 million during Q1 2021.
- Its 5-year average for Payables is $8.0 million, with a median of $8.5 million in 2024.
- Per our database at Business Quant, Foghorn Therapeutics' Payables surged by 14081.07% in 2022 and then crashed by 2905.67% in 2024.
- Quarter analysis of 5 years shows Foghorn Therapeutics' Payables stood at $9.6 million in 2021, then increased by 15.05% to $11.0 million in 2022, then fell by 17.21% to $9.1 million in 2023, then decreased by 6.34% to $8.5 million in 2024, then rose by 15.13% to $9.8 million in 2025.
- Its last three reported values are $9.8 million in Q3 2025, $8.6 million for Q2 2025, and $6.5 million during Q1 2025.